驗證網址www.r3i.org安全性

R3i - The Residual Risk Reduction Initiative

This analysis investigated real-world lipid lowering treatment based on the IMS LifeLink PharMetrics Plus commercial claims database. Patients who were initiated on statin ± ezetimibe were classified according to history of cardiovascular events (n=41,934...

網址安全性掃描由 google 提供